ADAPT trial: Endocrine + ribociclib vs. chemotherapy in HR+/HER2- early breast cancer

9.3K views

VJOncology

1 year ago

ADAPT trial: Endocrine + ribociclib vs. chemotherapy in HR+/HER2- early breast cancer

ADAPT trial: Endocrine + ribociclib vs. chemotherapy in HR+/HER2- early breast cancer